User:Mr. Ibrahem/Ertapenem

Ertapenem, sold under the brand name Invanz among others, is an antibiotic used for the treatment of infections in the abdomen, pneumonia, upper female reproductive system, urinary tract, and diabetic foot. It is given by injection into a vein or muscle.

Common side effects include diarrhea, nausea, headache, rash, and pain at the site of delivery. Other side effects may include Clostridium difficile-associated colitis, seizures, and allergic reactions including anaphylaxis. Use during pregnancy and breastfeeding appears to be safe, but has not been well studied. It is in the carbapenem family of medications, which usually results in the death of the bacteria.

Ertapenem was approved for medical use in the United States in 2001 and Europe in 2002. It is avaliable as a generic medication. In the United Kingdom it costs the NHS about £32 per dose. In the United States it costs about 34 USD per dose as of 2021.